Most strikingly, MAPK pathway mutations are also prognostic for markedly improved survival even among TP53-mutated patients (given TP53 mutations are usually indicators for HNSCC disease progression and disease aggressiveness) (Fig 1D). Here, TP53 is linked to head and neck squamous cell carcinoma.